Spyre Therapeutics, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Spyre Therapeutics, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Q2 2025

Aug 5, 2025

Earnings release8-K

Quarterly report10-Q

Status Update

Jun 17, 2025

Slides

Press release

Corporate Presentation

Jun 17, 2025

Slides

Q1 2025

May 8, 2025

Earnings release8-K

Quarterly report10-Q

TD Cowen 45th Annual Healthcare Conference

Mar 4, 2025

Slides

Corporate Presentation

Jan 13, 2025

Slides

2024

Q4 2024

Feb 27, 2025

Report

Annual report10-K

Study Result

Nov 12, 2024

Slides

Press release

Q3 2024

Nov 7, 2024

Quarterly report10-Q

Earnings release8-K

Q2 2024

Aug 7, 2024

Earnings release8-K

Q1 2024

May 9, 2024

Earnings release8-K

2023

Q4 2023

Feb 29, 2024

Annual report10-K

Earnings release8-K

Q3 2023

Nov 9, 2023

Earnings release8-K

Corporate Presentation

Oct 24, 2023

Slides

Q2 2023

Aug 11, 2023

Earnings release8-K

M&A Announcement

Jun 22, 2023

Slides

Press release

2022

Q4 2022

Mar 2, 2023

Annual report10-K

2021

Q4 2021

Mar 8, 2022

Annual report10-K

2020

Q4 2020

Mar 18, 2021

Annual report10-K

2019

Q4 2019

Feb 24, 2020

Annual report10-K

2018

Q4 2018

Mar 7, 2019

Annual report10-K

2017

Q4 2017

Mar 13, 2018

Annual report10-K

2016

Q4 2016

Mar 23, 2017

Annual report10-K